betty August 15, 2024

Brasilia, Brazil – August 14, 2024 – (SeaPRwire) – Kess Energy, a leading junior lithium mining company, is pleased to announce that its Chairman, Inato Ramirez, has purchased 200,000 shares of Kess Energy, further demonstrating his confidence in the company’s future growth and its commitment to delivering value to stakeholders. Strengthening Leadership Commitment The purchase of […]

megan August 14, 2024

The first ever copper-gold focused drilling program at the northern portion of the Nyngan Project will shortly commence with earn-in partner AngloGold Ashanti Australia (AngloGold Ashanti). New district-scale potential with up to eight large intrusive complex targets to be drill-tested for the first time in this initial first phase program. Approximately 6 to 8 drill […]

megan August 14, 2024

SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 stunning new additions to its exclusive “Lovers” collection. Originally launched in 2023, this exquisite wedding ring collection now embraces new designs that seamlessly blend timeless elegance with contemporary flair. ALUXE […]

betty August 14, 2024

Seoul, Korea – August 14, 2024 – (SeaPRwire) -The premium sleep and healthcare brand Dr.Friend’s pet sleep care product, Dr.Friend Puppy (owned by World Home Doctor Corp.), will be actively targeting overseas markets from the second half of the year. Dr.Friend Puppy will participate in the SUPER ZOO in Las Vegas, USA from August 14-16 to […]

betty August 14, 2024

New York, NY – August 14, 2024 – (SeaPRwire) – C14, a leading provider of fiat-to-crypto on and off-ramp solutions, has joined forces with Tune.FM, a cutting-edge music NFT trading platform, to release an off-ramp solution for JAM, the native token of the Tune.fm application. This collaboration marks a significant step forward in the integration of […]

megan August 14, 2024

MELBOURNE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Mark your calendars for an unmissable event! We are thrilled to announce our partnership with the upcoming Modern DevOps Melbourne, taking place on October 8, 2024, at the prestigious Grand Hyatt Melbourne. This event promises to be a cornerstone for industry leaders and innovators in […]

megan August 14, 2024

SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 stunning new additions to its exclusive “Lovers” collection. Originally launched in 2023, this exquisite wedding ring collection now embraces new designs that seamlessly blend timeless elegance with contemporary flair. ALUXE […]

paloma August 14, 2024

KYOTO, JAPAN, Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Valuufy, a pioneering fintech startup drawn from a decades’ work in measuring and creating sustainable value at Doshisha University’s Value Research Center, has launched with its groundbreaking ValuuCompass, a comprehensive framework set to transform sustainable business practices and sustainability investing by providing a fully […]

paloma August 14, 2024

TOKYO and CAMBRIDGE, Mass., Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (lecanemab) for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI […]

megan August 14, 2024

Development Highlights – During the reporting Period, four of the Group’s innovative products were approved for marketing by the National Medical Products Administration of China (“NMPA”), namely Andewei (Benmelstobart Injection), Anboni (Unecritinib capsules), Anluoqing (Envonalkib capsules) and Beilelin (Liraglutide Injection), three of which are national category 1 innovative drugs. – In the first half of […]

estel August 14, 2024

重点成果 – 期内,集团共有4个创新产品获中国国家药品监督管理局(「NMPA」)批准上市,分别为安得卫(贝莫苏拜单抗注射液)、安柏尼(富马酸安奈克替尼胶囊)、安洛晴(枸橼酸依奉阿克胶囊)和贝乐林(利拉鲁肽注射液),其中3个为国家…